Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Capacity building in anthelmintic drug discovery. Expert Opin Drug Discov 2007 Oct;2(s1):S75-82

Date

10/01/2007

Pubmed ID

23489035

DOI

10.1517/17460441.2.S1.S75

Abstract

International collaboration in anthelmintic drug discovery holds special challenges compared with local or national discovery projects, and at the same time presents the opportunity to build capacity, forge long lasting inter-institutional relationships and strengthen infrastructure in multinational priority areas. This chapter discusses important issues that should be considered in the context of anthelmintic screening centre development and will give examples (Philippines and Egypt) of the productivity of developing country based screening centres. The positive outcomes of infrastructure building is realised in greater capacities for anthelmintic screening at institutions in the countries where the parasitic diseases are endemic and allows for optimum use of specialised resources for public health priority diseases that may be different from those in Western countries. Support for developing country based screening centres also can help countries optimise product development procedures and policies and can facilitate diffusion of desirable technology in corresponding global regions around the world.

Author List

Kron M, Yousif F, Ramirez B

Author

Michael Kron MD Director, Professor in the Medicine department at Medical College of Wisconsin




jenkins-FCD Prod-388 89e904233d719332173309c68ab82b0b2a78a3a7